# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Truist Securities analyst Richard Newitter maintains Nevro (NYSE:NVRO) with a Hold and lowers the price target from $11 to $10.
Morgan Stanley analyst Cecilia Furlong maintains Nevro (NYSE:NVRO) with a Equal-Weight and lowers the price target from $14 ...
Citigroup analyst Joanne Wuensch maintains Nevro (NYSE:NVRO) with a Sell and lowers the price target from $9 to $8.2.
Citigroup analyst Joanne Wuensch downgrades Nevro (NYSE:NVRO) from Neutral to Sell and lowers the price target from $13.5 to...
Canaccord Genuity analyst William Plovanic maintains Nevro (NYSE:NVRO) with a Hold and lowers the price target from $17 to $11.
Wells Fargo analyst Nathan Treybeck maintains Nevro (NYSE:NVRO) with a Equal-Weight and lowers the price target from $14 to ...
Piper Sandler analyst Adam Maeder maintains Nevro (NYSE:NVRO) with a Underweight and lowers the price target from $15 to $12.